These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 30326113)

  • 1. Extending the User Fee Approach to Pharmaceuticals.
    Cutler DM
    JAMA; 2018 Oct; 320(15):1525-1526. PubMed ID: 30326113
    [No Abstract]   [Full Text] [Related]  

  • 2. FDA and drug safety: new Tufts study challenges critics of the Prescription Drug User Fee Act.
    Lee R
    J Law Med Ethics; 2006; 34(1):131-4. PubMed ID: 16489994
    [No Abstract]   [Full Text] [Related]  

  • 3. The Prescription Drug User Fee Act: is a faster Food and Drug Administration always a better Food and Drug Administration?
    Zelenay JL
    Food Drug Law J; 2005; 60(2):261-338. PubMed ID: 16094773
    [No Abstract]   [Full Text] [Related]  

  • 4. The Prescription Drug User Fee Act of 1992: speeding up the drug approval process.
    Bierut MB
    Healthspan; 1992 Dec; 9(11):12-4. PubMed ID: 10123552
    [No Abstract]   [Full Text] [Related]  

  • 5. 'Must-pass' FDA fee renewal jammed with sunscreen and more.
    Scheinbaum C
    Nat Med; 2012 Jul; 18(7):990. PubMed ID: 22772529
    [No Abstract]   [Full Text] [Related]  

  • 6. Regulatory watch: impact of PDUFA on regulatory decision-making.
    Hay M
    Nat Rev Drug Discov; 2010 Aug; 9(8):585. PubMed ID: 20671755
    [No Abstract]   [Full Text] [Related]  

  • 7. Controversy still swirls around FDA user fees: since 1992, the prescription drug user fee act and reauthorizations have sped up new drug approvals--but does speed equal safety?
    Ullman K
    Ann Neurol; 2013 Nov; 74(5):A10-1. PubMed ID: 24353218
    [No Abstract]   [Full Text] [Related]  

  • 8. FDA user fees and innovation.
    Somberg J
    Am J Ther; 2008; 15(2):97. PubMed ID: 18356626
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmaceuticals and Medical Devices: Cost Savings.
    Steiner DJ;
    Issue Brief Health Policy Track Serv; 2018 Dec; 2018():1-31. PubMed ID: 30695849
    [No Abstract]   [Full Text] [Related]  

  • 10. FDA user-fee bill seen as speeding approvals, but harming smaller firms.
    Kacik A
    Mod Healthc; 2017 Apr; 47(17):11. PubMed ID: 30476419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are drugmakers fishing for a market with prescription omega-3s?
    Hersher R
    Nat Med; 2012 Jan; 18(1):6. PubMed ID: 22227649
    [No Abstract]   [Full Text] [Related]  

  • 12. Reconciling Estimates of the Value to Firms of Reduced Regulatory Delay in the Marketing of Their New Drugs.
    Wilmoth DR
    Health Econ; 2015 Dec; 24(12):1651-6. PubMed ID: 25753390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FDA dependence on drug industry.
    Lawson GW
    J Natl Med Assoc; 2005 Jul; 97(7):1039-40. PubMed ID: 16080677
    [No Abstract]   [Full Text] [Related]  

  • 14. User fees and beyond--the FDA Safety and Innovation Act of 2012.
    Kramer DB; Kesselheim AS
    N Engl J Med; 2012 Oct; 367(14):1277-9. PubMed ID: 23034017
    [No Abstract]   [Full Text] [Related]  

  • 15. FDA joins market.
    Gershon D
    Nature; 1993 Jul; 364(6433):93. PubMed ID: 8321293
    [No Abstract]   [Full Text] [Related]  

  • 16. Economic Impacts of the Generic Drug User Fee Act Fee Structure.
    Dong K; Boehm G; Zheng Q
    Value Health; 2017 Jun; 20(6):792-798. PubMed ID: 28577697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New FDA law will help preserve production of "life-saving" drugs.
    Thompson CA
    Am J Health Syst Pharm; 2012 Aug; 69(16):1352, 1354. PubMed ID: 22855095
    [No Abstract]   [Full Text] [Related]  

  • 18. Paying for drug approvals--who's using whom?
    Avorn J
    N Engl J Med; 2007 Apr; 356(17):1697-700. PubMed ID: 17435083
    [No Abstract]   [Full Text] [Related]  

  • 19. An Incomplete Prescription: President Trump's Plan to Address High Drug Prices.
    Sarpatwari A; Avorn J; Kesselheim AS
    JAMA; 2018 Jun; 319(23):2373-2374. PubMed ID: 29800027
    [No Abstract]   [Full Text] [Related]  

  • 20. PDUFA reauthorization--drug safety's golden moment of opportunity?
    Hennessy S; Strom BL
    N Engl J Med; 2007 Apr; 356(17):1703-4. PubMed ID: 17435082
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.